Dx Knowledge Hub - Expanded use case analysis for Rapid antigen diagnostics for SARS-CoV-2 mitigation (Phase 2)

ACT-A Dx Knowledge Hub

Home | Resource Centre - Publications | Expanded use case analysis for Rapid antigen diagnostics for SARS-CoV-2 mitigation (Phase 2)

Expanded use case analysis for Rapid antigen diagnostics for SARS-CoV-2 mitigation (Phase 2)

Expanded use case analysis for rapid antigen diagnostics for SARS-CoV-2 mitigation. Phase 2 results from the ACT-Accelerator SARS-CoV-2 rapid antigen testing modelling consortium.

Download Report

Related News

Use of Digital Tools to Strengthen COVID-19 Management – Case Study Nigeria

Information Note for CSOs on COVID-19 Testing

FIND and partners from the Access to COVID-19 Tools (ACT) Accelerator Diagnostics Pillar call on the G20 and G7 to prioritize diagnostics in its pandemic preparedness and response plans

Call to G20 leaders to uphold diagnostics and equitable access to testing